Masimo’s family of continuous and spot-check monitoring Pulse CO-Oximeters ® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless ...

Masimo’s family of continuous and spot-check monitoring Pulse CO-Oximeters® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless ...

Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient ...

Masimo’s family of continuous and spot-check monitoring Pulse CO-Oximeters® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless ...

Advancements in MRI-compatible medical devices, including improved sensor technologies and wireless capabilities ... and adults in fixed-site as well as mobile MRI units. Masimo launched two health ...

Masimo’s family of continuous and spot-check monitoring Pulse CO-Oximeters ® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless ...

In September, Masimo announced its MightySat Medical fingertip pulse oximeter was the first to win FDA clearance for over-the-counter use. That device also performed well in the independent ...

Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient ...

After hours: December 6 at 6:18:26 PM EST Loading Chart for MASI ...

A federal district court in California construed disputed claim terms in Masimo Corp.'s action against Apple Inc. for infringement of patents for low power pulse oximeters. The court construed ...

As for the retrial between Masimo and Apple Inc., a verdict has yet to be reached. The bench trial, which began on Nov. 5, is a trade secret case over pulse oximetry technology used in smart watches.